Aytu BioPharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aytu BioPharma using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-11-13 | $-0.08 | $-0.14 | 42.9 % |
| Q4 | 2025-09-23 | $-0.25 | $-0.04 | -525.0 % |
| Q3 | 2025-05-14 | $0.21 | $-0.17 | 223.5 % |
| Q2 | 2025-02-12 | $-0.28 | $0 | -100.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-11-13 | $13.90M | $12.61M | 10.3 % |
| Q4 | 2025-09-23 | $15.14M | $17.98M | -15.8 % |
| Q3 | 2025-05-14 | $18.45M | $13.74M | 34.3 % |
| Q2 | 2025-02-12 | $16.22M | $15.55M | 4.32 % |
Aytu BioPharma (AYTU) is scheduled to report earnings on February 11, 2026. The last reported earnings were for reported on November 13, 2025 for Q1.
The Actual EPS was $-0.08, which beat the estimate of $-0.14.
The Actual Revenue was $13.9M, which beat the estimate of $12.6M.
Browse earnings estimates, EPS, and revenue on all stocks.